Peritransplant Ruxolitinib for Patients With Primary and Secondary Myelofibrosis
Clinical trial NCT04384692 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04384692
- Sponsor
- Fred Hutchinson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-18
- Primary completion
- 2026-04-03
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.